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ABSTRACT
An experiment of 45 days duration to test the efficacy of the  Vibrio alginolyticus as an immunostimulant
was conducted in  Marsupenaeus japonicus  against white spot syndrome virus (WSSV) infection, considered
as one of the serious pathogens of shrimps. The shrimps were fed with the experimental diets coated with
different concentrations of bacteria of 17 ml / kg feed and 10 % of animal body wt. They were challenged
with WSSV to assess the increase in survival rate and growth if any due to immune enhancement. Another
group of shrimp was used for  drawing the haemolymph to estimate the increase in the level of prophenoloxidase
activity. Samplings for the above said analysis were carried out at 15 days interval for a period of 45 days.
The highest prophenoloxidase activity (39.78 with sand substrate-T1) and the highest survival rate (66.66 %
with sand substrate-T1) and highest growth rate (7.04 % in 17ml/kg- with sand substrate-T1) were recorded
in experimental diet (17 ml / kg feed). Hence the 17 ml / kg feed of Vibrio alginolyticus formalin killed added
to the diet could be an eco-friendly and economically viable immunostimulant for penaeid shrimps.
Key words : Kuruma Shrimp, Marsupenaeus japonicus, Prophenoloxidase activity, Vibrio alginolyticus,
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INTRODUCTION
Shrimp culture has undergone rapid development in
most south-east Asian countries, but successful
production is increasingly hampered especially by
diseases in addition to environmental pollution and
poor management practices. Of all the infectious
diseases, bacterial infections cause serious
diseases like vibriosis, ulcer disease, tail rot, necrosis
etc. Vibriosis, especially luminescent disease caused
by Vibrio harveyi leads to mass mortality in the
shrimp hatcheries (De la Pena et al., 1993).
At present Shrimp culture in India has high
susceptibility to a plethora of diseases which resulted
severe loss. Traditionally, treatment of shrimp
diseases was carried out by the use of chemical
and antibiotic products. Chemical treatment is
intricate mainly due to the huge requirement of
chemicals needed to produce the desired
therapeutic effect and the after effects of hither to
unknown consequences of such treatment to the
ecosystem. The fear of development of plasmid
mediated resistant strains of bacteria to antibiotics
(Gabriel AG and Felipe  AV, 2000) and accumulation
in the shrimp, restricts continuous use of the
antibiotics. However, this indiscriminate and
unabated usage of chemicals and antibiotics has led
a serious debate amongst environmentalist and
governmental agencies for complete ban of these
products. These reasons paved way for the
development of wide array of strategies in sustaining
the shrimp aquaculture. Thus, the concept of
biological disease control, particularly using non-
pathogenic bacterial strains for disease prevention
has received wide spread attention during the last
decade (Gram, et al., 1999).
Effective vaccination of penaeid shrimps with a
formalin – killed Vibrio spp. vaccine has been
reported by Kou et al. (1989) and Itami et al. (1989).
However, study on the development of V.harveyi
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vaccine and its effect on vibriosis in Fenneropenaeus
indicus was found scarce.In the present study, a
more effective way of protecting cultivable penaeid
shrimps against vibriosis, by using formalin - killed
V.alginolyticus as immunostimulant was developed
and the relative percent survival (RPS) of
immunostimulated against control Marsupenaeus
japonicus and growth was also investigated.
MATERIALS AND METHODS
Experimental Design
The experiment was conducted at Muttukkadu
Experimental Station of Central Institute of
Brackishwater Aquaculture, CIBA, Chennai. for a
period of 45 days in six distinct experimental groups
namely C1, T1, T2 (with sand substrate) and C2,
T3, T4 (without sand substrate) with each group
having three replicates including controls. Uniform
size Fiberglass Reinforced Polypropylene (FRP)
tanks of 100 L capacity each were cleaned and
disinfected with bleaching powder before starting the
experimental trial. The tanks were filled with 70 L of
filtered seawater and continuous aeration was
provided throughout the experimental period.
The juvenile shrimp average weight 4 ± 2 g with
2 nos/m2 density were stocked in100 L tank capacity.
The juveniles of Marsupenaeus japonicus  from
single broodstock were obtained from CIBA hatchery.
PCR test was done before the shrimps were used
for the experimental trials.
Immunostimulant Preparation
Innoculum of pure Vibrio spp., viz., V. alginolyticus,
were cultured individually in pre-sterilized alkaline
peptone water broth (15g / l, pH 7.4, 1% NaCl), at
room temperature for 48 hrs. After 48 hrs, the
bacterial preparation was harvested by centrifugation
at 8000 rpm for 5 min at 4°C. The supernatant was
collected and the pellet was resuspended in sterile
Phosphate Buffer Solution (PBS) .The cultures were
inactivated by formalin method: Adding 0.5% Formalin
to 1 L of bacterial culture (Akhlaghi, 1999). The
sterility test of killed bacteria was conducted by
inoculating the preparation on TCBS plates and
incubating at 37°C for 24 hours. The formalin killed
bacterial cultures were diluted individually in PBS to
give a series of concentration of 105 – 109 cells / ml.
The solutions were stored in glass bottles at 4°C till
further use. However, during the suspension of
desired concentration was prepared fresh, mixed
with the shrimp feed and sun dried for 2-3 hours
before feeding.
The experimental animals were fed with commercial
shrimp feed (2mm size).  Two experimental diets
using commercial feed were mixed with T1 (17 ml
(1 x 108 cells)/kg), T2 (10% of animal body wt.) (with
sand substrate) and T3, T4 (without sand substrate)
and each of with formalin killed Vibrio alginolyticus
bacterial suspension and dried for 1 hour before
feeding. The control feed C1, C2 (with sand
substrate) and C3, C4 (without sand substrate) were
devoid of any bacterial suspension. The juveniles
were fed thrice a day at 08.00 hrs, 14.00 hrs and
18.00 hrs at the rate of 8% of the body weight per
day. The daily allowance was divided into three equal
portions. The rate of feeding was adjusted daily
depending on the feed consumptions. Complete
(100%) water exchange was carried out in all the
tanks everyday. Daily, before water exchange, abiotic
parameters – salinity, pH and temperature were
recorded. Before water exchange, samples were
collected twice a week and estimated for ammonia
and nitrite using standard methods.
Parameters for evaluating efficacy of
immunostimulant :
Growth Rate
In order to assess the growth performance in the
tank, sampling was conducted in the tank regularly
with the Ricker, W. E. (1979) methodology. The final
weight of the shrimps was taken at the end of the
study (45 days); growth percentage and survival
percentage (Sung et al., 1994) were calculated using
the formulae given below.
Growth% = 
( )Final weight Initial weight of shrimps




( )Final number Initial number of shrimps
Initial number of shrimps
 100
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Prophenoloxidase Activity Assay
Prophenolxidase activity (proPO) in haemocytes of
shrimp’s haemolymph was measured by the
formation of dopachrome from L-Dihydroxy-
phenylalanine (DOPA) (Soderhall and Unestam,
1979) on a Multiscan ELISA reader. Prophenol-
oxidase activity (proPO) in the haemolymph of M
japonicus fed with or without immunostimulant was
estimated. 500µl of haemolymph was drawn from
the ventral sinus (5th pleiopod) of shrimp in a    1000
µl syringe pre-chilled with 0.5 ml of cold
anticoagulant solution. The haemolymph was
collected in pre-cooled Eppendoff’s vials  (2 ml). The
samples were thawed and immediately analyzed for
proPO activity. The haemolymph collected and
centrifuged at 5000 rpm for 5 min and the supernatant
fluid i.e., haemocyte lysate supernatant (HLS) was
separated from plasma protein for determination. The
cell suspension was incubated with Cacodylate
buffer for 30 min at room temperature. At the end of
incubation, the mixture was centrifuged for 3 min at
6000 rpm. The supernatant was collected and
estimated for proPO activity.
ELISA Reading
Triplicates of 50µl of haemolymph sample were taken
and to which 50µl of trypsin was added and incubated
at room temperature. After 20 min of incubation, 50µl
of L-DOPA was added and the optical density was
measured at 490 nm on an ELISA reader every one
minute interval for 5 minutes. Protein concentrations
of haemolymph were determined by Lowry et al.,
(1951), method.  To 1 ml of diluted protein standard
(BSA) and haemolymph sample, 5 ml of alkaline
copper sulphate was added and mixed thoroughly.
The solution was put under incubation. After 30
minutes, the blue colour so developed was
measured at 640 nm using UV-Spectrophotometer
(Shimadzu). Using the standard curve, protein
concentration of unknown samples were determined
by plotting concentration (mg / ml) of BSA against
standard 640 nm . One enzyme activity unit was
equivalent to an increase of 0.001 in absorbance.
Prophenoloxidase (unit/min/mg of protein) was
calculated using the formula.
Change in









nd st rd nd th rd th th       
Prophenoloxidase level  = 
Change in absorbance
otein value of plasmaPr
Challenge studies
The tank cultured shrimps from both treatment and
control tanks were challenged with V.alginolyticus
as well as White Spot Syndrome Virus (WSSV).  The
harvested live shrimps from both treatment and
control were maintained in troughs (15 l) and
acclimatized for 24 hours prior to the challenge test.
The infected WSSV shrimp were cut into small
pieces and fed at the rate of 3% of the body weight
of the shrimps to both groups-treatment and control
groups which were maintained separately.  After 4
hours of feeding the residual feed and water was
removed and replaced with fresh sea water.  The
shrimps were fed with commercial feed till the
conclusion of the experiment.  On forty-five days of
post vaccination, the Juveniles were challenged with
V. harveyi (6.1x105 cfu/ml- challenge dose) and the
mortality of the shrimps was recorded for a period
of 5 days (Itami et al., 1989). Mortality number and
time of death was monitored for 7 days and clinical
signs were verified by re-isolation of WSSV from
freshly challenged dead shrimp or survivors through
PCR tests.  Cumulative mortality was registered and
percent survival was calculated.
Polymerase chain reaction (PCR) screening for
WSSV :
WSSV Isolation and Preparation
Virus used in this study originated from an infected
shrimp farm located near Muthukadu, Chennai. The
presence of WSSV in infected shrimp was confirmed
by PCR analysis of DNA isolated. The WSSV stock
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solution was prepared following the method of Tsai
et al. (2000). Infected shrimp were homogenized in
TNE and then centrifuged at 1700xg for 10 min at
4°C. The supernatant was filtered through a 0.45 ìm
membrane and was stored at -80°C until used for
challenging.
Detection of WSSV
Different parts of shrimp body such as pleopods,
gills and tail were cut using a sterilized scissor. The
parts were immediately digested using the
solubilising buffer (NaOH -100 µl of 0.05 N, Sodium
dodecylsulphate solution-0.025%).  The contents
were thoroughly homogenized with a Teflon
homogenizer and the same was placed in water bath
at 100°C for 5 min and then centrifuged at 6000 rpm
for 5 min. 5 µl of the collected supernatant were
transferred to PCR tubes. PCR cocktail reagents
were added and the contents of the PCR vials were
mixed gently by tapping with the fingers. The
amplification of DNA molecules was performed using
the PCR program specific to the kit (WSSV detection
kit, Genei, Bangalore and CIBA, Chennai) was used.
Statistical Analysis :
The data collected on the different parameters of the
experimental study was subjected to statistical
analysis by one way analysis of variance ANOVA
(Snedecor and Cochran, 1968), the statistical level
of significance was tested at 1% and 5% levels.
RESULTS AND DISCUSSION
Effect of immunostimulant on growth percentage
An insignificantly higher (P < 0.05) growth percentage
was observed irrespective of the treatments
compared to control groups.  The highest growth
percentage was recorded in treatment group (T1)
compared to other groups over the period of 45 days
with the sand substrate (Table 1). There is no
significant difference between the control and
treatment groups (C1, T1 and C1, T2). Similarly there
is no significant difference (P > 0.05) between the
control and treatment groups (C2, T3 and C2, T4) in
without sand substrate during the experimental
period. The maximum average mean value of growth
percentage was found to be 7.033 + 0.274 in with
sand substrate treatment group (T1) compared to
other groups.
Table 1 : Growth percentages of Kuruma shrimp
(M. japonicus) fed with immunostimulant reared with
and without sand substrate in 45 days of
experimental duration.




1. Control C1 6.149 + 0.269a
2. 17 ml / kg feed T1 7.033 + 0.274a
3. 10 % of animal body wt. T2 6.676 + 0.271a
Without sand substrate
4. Control C2 6.472 + 0.244a
5. 17 ml / kg feed T3 6.494 + 0.234a
6. 10 % of animal body wt. T4 6.665 + 0.169a
Means not sharing a common superscript letter
between column values for each indexes differ
significantly (P < 0.05).
Effect of immunostimulant on Prophenoloxidase
activity
Prophenoloxidase activity observed significant
difference (P < 0.05) between control and treatment
groups in with sand substrate (Table 2). The highest
Prophenoloxidase activity was recorded in treatment
group T1, 39.78 + 0.365 compared to other groups
over a period of 45 days with sand substrate. There
is no significant difference (P > 0.05) between the
treatment groups (T3 and T4) but there were
significant difference between control and treatment
groups (C2, T3 and C2, T4) in without sand substrate
during the experimental period.
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Table 2 : Prophenoloxidase -Activity in haemolymph
of kuruma shrimp M. japonicus fed with
immunostimulant reared with and without Sand
substrate in 45 days period.
Serial Treatment Tank Prophenoloxidase
Number Nos. Activity(units /
min / mg / protein)
(Mean + S.E.)
With sand substrate
1. Control C1 29.98 + 0.215a
2. 17 ml / kg feed T1 39.78 + 0.365b
3. 10 % of  animal body wt. T2 38.81 + 0.317c
Without sand substrate
4. Control C2 33.14 + 0.384a
5. 17 ml / kg feed T3 39.01 + 1.163b
6. 10 % of animal body wt. T4 39.62 + 0.342b
Means not sharing a common superscript letter
between column values for each indexes differ
significantly (P < 0.05).
Effect of immunostimulant on survival
percentage
Survivay percentage showed that shrimps reared
with and without sand substrate at the end of 45 days
of feeding with immunostimulant had complete
mortality (100%) in the 4th day of post challenge in
both control groups (C1 and C2) (Table 3). But in
with sand substrate treatment groups (T1 and T2)
were recorded in the survival of shrimps in the 7th
day of post challenge The highest survival was found
to be 66.66 + 2.842 in with sand substrate treatment
group (T1) compared to other treatment and control
groups. A PCR test was conducted randomly to
check whether shrimps have positive or negative
WSSV in all the experimental tanks. It was found
that all treatment groups showed negative results
except without sand substrate control group which
showed positive result of WSSV (Fig. 1 and 2).
Table 3 : Survival percentages of Kuruma shrimp
(M. japonicus) fed with immunostimulant reared with
and without sand substrate for a period of 45 days.




1. Control C1 38.33 + 1.123a
2. 17 ml / kg feed T1 66.66 + 2.842b
3. 10% of animal body wt. T2 50 + 3.015c
Without sand substrate
4. Control C2 41.66 + 4.578a
5. 17 ml / kg feed T3 58.33 + 3.859b
6. 10% of animal body wt. T4 56.33 + 3.859b
Means not sharing a common superscript letter
between column values for each indexes differ
significantly (P <0.05)
Fig. 1 : Agarose Gel before the Challenge Test from
shrimp Marsupenaeus japonicus  fed with
immunostimulant for the period of 45 days.
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Lane M-Marker, Lane 1 to 2 -C1, C2, Lane 3 to 6 -T1,
T2, T3, T4, Lane 7 to 8-C3, C4, Lane 9 to 11-T5, T6,
T7, T8, Lane N-Negative, Lane P-Positive
Fig. 2 : Agarose Gel after the Challenge Test from
shrimp Marsupenaeus japonicus  fed with
commercial feed for the period of 45 days.
Lane M-Marker, Lane 1 to 2-C1& C2, Lane 3 to 6-T1,
T2, T3, T4, Lane 7 to 8-C3, C4
Lane 9 to 11-T5, T6, T7, T8, Lane N-Negative, Lane
P-Positive
Different approaches to prevent shrimp diseases
have normally involved antibiotics, vaccination
against specific pathogens and even different
immunostimulants that protect shrimps
nonspecifically. Till some years ago scientists
believed that shrimps do not possess acquired
immunity but recent studies showed that shrimps
have acquired immunity and even memory cells that
make the vaccinations efficient in these groups of
animals (Van Hulten, et al., 2009). In present study
we compared two immunostimulants i.e. (a) 17ml /
kg feed (b) 10% of animal body wt. in two types of
substrates (a) with sand substrate, (b) without sand
substrate in Kuruma shrimp, Marsupenaeus
japonicus looking at its commercial importance.
Physiological concentration and the efficacy of
immunostimulants were also tested.
The growth percentage was found to be higher in all
the treatment groups than the control group. The
highest growth percentage was observed in 17ml/
kg feed treatment group T1 (7.033 + 0.274) and the
lowest growth percentage was recorded in 10% of
animal body wt. treatment groups T2 (6.676 + 0.271)
fed with immunostimulants. In without sand substrate
experimental groups, percentage of growth was
found to be higher in all the treatment groups than
the control group, C2 was 6.472 + 0.244 for a period
of 45 days.  This result is in accordance with study
by Montero-Rocha et al. (2006); that showed an
increase in body weight during 15 days of using
Ergosan in intermoult stage shrimp. Similarly, (Sang
HM and Fotedar R, 2004) recorded the highest
growth of western king prawn, Penaeus latisulcatus
reared at 34 ppt followed by 22 ppt and 46 ppt. The
result obtained in the present study is concurrent
with the results obtained by (Muthu MS, 1980) and
(Liao IC, 1988). The enhanced survival and growth
with immunostimulation suggests that immuno-
stimulant elevates the physiological condition and
possibly it has an indirect role in the osmoregulation
process.
Prophenoloxidase is the key enzyme in the
syntheses of melanin. It occurs in haemolymph as
an inactive pro-enzyme prophenoloxidase (proPO)
and is activated when it reacts with zymosan
(carbohydrates for yeast cell walls), bacterial
lipopolysaccharide (LPS), urea, calcium ions, trypsin,
or heat and converts to active form as proPO. This
active proPO is one of the terminal components of a
cascade of proteolytic reactions that accompany the
recognition of foreign materials in numerous
crustaceans and insects (Soderhall K et.al., 1990),
(Johansson M W and Soderhall K, 1992) (Nappi A
and Vass E, 1993a) and (Nappi AJ and Sugumaran
M, 1993b). Results from several experiments of the
putative proPO activating system, stimulate several
cellular defence reactions, including phagocytosis,
module formation, encapsulation and haemocyte
locomotion (Soderhall K and Smith VJ, 1986).
At the end of 45 days the prophenoloxidase activity
was estimated from the haemolymph in the treatment
and control group. All the treatment groups showed
higher prophenoloxidase activity than the control
groups with sand substrate and without sand
substrate. With sand substrate group, highest mean
prophenoloxidase activity was recorded in 17 ml /
kg feed treatment group T1 (39.78 + 0.365) than 10
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% of animal body wt. treatment group T2 (38.81 +
0.317). But the case of without  sand substrate
experimental groups showed highest prophenol-
oxidase activity in 17 ml / kg feed treatment group
T3 (39.01 + 1.163) than 10% of animal body wt.
treatment group T4 (39.62 + 0.342) and followed by
the control group C2 ( 33.14 + 0.384).
The prophenoloxidase factor as a measure of
immune enhancement in penaeid shrimps had been
demonstrated in number of studies (Soderhall K,
Cerenius L and Johansson MW, 1996), (Vargas-
Albores F, Jimenez-Vega F and Soderhall K, 1996),
(Perazzolo LM and Barracco MA, 1997), (Devaraja
et al., 1998) ;(Karunasagar I and Karunasagar I,
1999a) and (Karunasagar I and Karunasagar I,
1999b), (Felix et al., 2004) (Citarasu et al., 2006)
observed that prophenoloxidase value increased
significantly in the shrimps fed with immunostimulant,
while in immunostimulant deficient control groups, it
decreased. In the present study the prophenal-
oxidase was high in with sand substrate treatment
tanks compared to without sand substrate treatment
groups, in 17 ml/ kg feed immunostimulant. But it
was noticed that prophenoloxidase activity was less
in both the control groups. The prophenoloxidase
(proPO) activity of haemolymph, an important
enzyme linked mediator of  crustacean immunity has
been demonstrated to be an effective tool that can
be used independently or along with challenge
studies for confirmation of immune  enhancement
pattern in penaeid shrimps. The  effectiveness of
the Vibrio vaccine as an immunostimulant in penaeid
shrimps is comparable to  those of other
immunostimulants (LPS, chitin and â-Glucan) tested
with proPO effects (Felix S and Sivakumar, 2003).
The survival percentage was found to be higher in
all the treatment groups than the control group, C1
was 38.33 + 1.123. The highest survival was
recorded in 17 ml/ kg feed treatment group T1 was
66.66 + 2.842.  The lowest survival was recorded in
10% of animal body wt. treatment groups T2 was 50
+ 3.015. The highest survival was observed in 17 ml
/ kg feed of immunostimulant concentration
compared to 10 % of animal body wt. of immuno-
stimulant concentration.
Without sand substrate experimental group’s
survival percentage found to be higher in all the
treatment groups than the control group, C2 was
41.66 + 4.578. The highest survival in 17ml/kg feed
treatment group recorded in T3 was 58.33 + 3.859
and followed by lowest survival in the 10% of animal
body wt. treatment group T4 was 56.33 + 3.859.
Compared to with sand substrate the survival was
low in without sand substrate. The different
parameters of the present work revealed that the
immunostimunats are very effective against WSSV
infection and the outcome of the results will serve
long way towards the sustainable shrimp culture
which at present struggling under the  impact of
disease threat.
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